MARKET

QDEL

QDEL

Quidel
NASDAQ

Real-time Quotes | Nasdaq Last Sale

196.77
+4.81
+2.51%
Closed 19:27 09/25 EDT
OPEN
191.81
PREV CLOSE
191.96
HIGH
197.81
LOW
187.75
VOLUME
575.91K
TURNOVER
--
52 WEEK HIGH
306.72
52 WEEK LOW
55.25
MARKET CAP
8.25B
P/E (TTM)
55.09
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The Pandemic Speeds Up the Health-Care Revolution
The drive to quickly conquer Covid-19 has accelerated innovation across the health-care sector. Barron’s roundtable experts highlight the most promising...
marketwatch.com · 2d ago
Top Healthcare Stocks for October 2020
These are the healthcare stocks with the best value, fastest growth, and most momentum for October 2020.
Investopedia · 3d ago
Quidel (QDEL) Stock Moves -1.39%: What You Should Know
Quidel (QDEL) closed at $196.21 in the latest trading session, marking a -1.39% move from the prior day.
Zacks · 4d ago
FOCUS-Positive about flying? Airlines look to COVID tests that give results in minutes
Reuters · 5d ago
I Ran A Stock Scan For Earnings Growth And Quidel (NASDAQ:QDEL) Passed With Ease
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Simply Wall St. · 6d ago
How To Avoid The Noise And Invest For Long-Term Success
Let's face it, today's retail investor is bombarded with information, and parsing through what is useful and what is not can be challenging.Avoiding noise and executing under pressure are critical to investing success.I've been managing custom-built equity portfolios since 2012, and hope to engage with those on Seeking Alpha interested in long-term investment success.I will look to do this with the tools I've developed to manage portfolios.
Seekingalpha · 6d ago
Is Quidel (QDEL) Stock Outpacing Its Medical Peers This Year?
Is (QDEL) Outperforming Other Medical Stocks This Year?
Zacks · 6d ago
FOCUS-U.S. plans for hundreds of millions of cheap, fast COVID-19 tests
Manufacturing and government sources tell Reuters that more than half a dozen so-called antigen tests will likely be authorized by the end of October. U.S. regulators in recent months have authorized antigen tests from Abbott Laboratories , Becton Dickinson & Co , Quidel Corp and LumiraDX. When
Reuters · 09/17 12:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of QDEL. Analyze the recent business situations of Quidel through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average QDEL stock price target is 264.75 with a high estimate of 363.00 and a low estimate of 160.00.
EPS
Institutional Holdings
Institutions: 414
Institutional Holdings: 41.79M
% Owned: 99.63%
Shares Outstanding: 41.95M
TypeInstitutionsShares
Increased
88
5.29M
New
184
1.24M
Decreased
84
8.22M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.83%
Healthcare Equipment & Supplies
+2.01%
Key Executives
Chairman/Independent Director
Kenneth Buechler
Chief Executive Officer/President/Director
Douglas Bryant
Chief Financial Officer
Randall Steward
Chief Operating Officer
Robert Bujarski
Senior Vice President
Michael Abney
Senior Vice President
Ratan Borkar
Senior Vice President
Karen Gibson
Senior Vice President
Werner Kroll
Senior Vice President
Edward Russell
Director
Ann Rhoads
Independent Director
Edward Michael
Independent Director
Kathy Ordonez
Independent Director
Mary Polan
Independent Director
Charles Slacik
Independent Director
Matthew Strobeck
Independent Director
Ken Widder
Independent Director
Kenneth Widder
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About QDEL
Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid immunoassays, cardiac immunoassay, specialized diagnostic solutions and molecular diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of many diseases and medical conditions, including infectious diseases, cardiovascular diseases and conditions, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Amplivue, Lyra and Thyretain.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Quidel Corporation stock information, including NASDAQ:QDEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QDEL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QDEL stock methods without spending real money on the virtual paper trading platform.